Cutaneous non-Langerhans' cell histiocytoses;Die kutanen non-Langerhanszell-histiozytosen

JDDG - Journal of the German Society of Dermatology

Volumn 1, Issue 6, 2003, Pages 471-492

  Utikal, Jochen ^a   Klemke, Claus Detlev ^a   Gratchev, Alexei ^a   Goerdt, Sergij ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; JUVENILE XANTHOGRANULOMA; MACROPHAGE ACTIVATION; NECROBIOTIC DISORDER; RETICULOHISTIOCYTOSIS; REVIEW; SKIN BIOPSY; XANTHOGRANULOMA; ADULT; CHILD; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; IMMUNOLOGY; INFANT; MALE; PATHOLOGY; PRESCHOOL CHILD; SKIN; SKIN DISEASES;

ADULT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INFANT; MALE; SKIN; SKIN DISEASES;

EID: 0038374323     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1610-0387.2003.03551.x     Document Type: Review

References (147)

1. Furth v R, Langevoort HL, Schaberg A. Mononuclear phagocytes in human pathology - proposal for an approach to improved classificatio. In: Mononuclear phagocytes in immunity, infection, and pathology. Oxford, London, Edinburgh, Melbourne: Blackwell Scientific Publications, 1975: 1-15.
2. Tew JG, Thorbecke GJ, Steinman RM. Dendritic cells in the immune response: characteristics and recommended nomenclature (A report from the Reticuloendothelial Society Committee on Nomenclature). J Reticuloendothel Soc 1982; 31: 371-80.
3. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987; 1: 208-09.
4. Kashihara-Sawami M, Horiguchi Y, Ikai K, Takigawa M, Ueda M, Hanaoka M. Letterer-Siwe disease: immunopathologic study with a new monoclonal antibody. J Am Acad Dermatol 1988; 18: 646-54.
5. Pinkus GS, Lones MA, Matsumura F, Yamashiro S, Said JW, Pinkus JL. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker. Am J Clin Pathol 2002; 118: 335-43.
6. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH. Langerhans'-cell histiocytosis (histiocytosis X) - clonal proliferative disease. N Engl J Med 1994; 331: 154-60.
7. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343: 767-68.
8. Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993; 15: 291-98.
9. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993; 15: 92-98.
10. Henter JI, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 291-822.
11. Goerdt S, Kolde G, Bonsmann G, Hamann K, Czarnetzki B, Andreesen R. Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J Pathol 1993; 170: 421-27.
12. Adamson NF. Congenital xanthoma multiplex in a child. Br J Dermatol 1905; 17: 222-23.
13. McDonagh JER. Spontaneous disappearance of an endothelioma (nevo-xanthoma). Br J Dermatol 1909; 21: 254-56.
14. McDonagh JER. A contribution to our knowledge of the naevo-xantho-endotheliomata. Br J Dermatol 1912; 24: 86-99.
15. Montgomery H, Osterberg AE. Xanthomatosis. Correlation of clinical histopathologic and chemical studies of cutaneous xanthoma. Arch Dermatol Syphilol 1938; 37: 375-402.
16. Goerdt S, Walsh LJ, Murphy GF, Pober JS. Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol 1991; 113: 1425-37.
17. Kodelja V, Goerdt S. Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Exp Dermatol 1994; 3: 257-68.
18. Zelger BW, Sidoroff A, Orchard G, Cerio R. Non-Langerhans cell histiocytoses. A new unifying concept. Am J Dermatopathol 1996; 18: 490-504.
19. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176: 287-92.
20. Zlotnik A, Moore KW. Interleukin 10. Cytokine 1991; 3: 366-71.
21. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-50.
22. Takeuchi M, Kosiewicz MM, Alard P, Streilein JW. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol 1997; 27: 1648-56.
23. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137-42.
24. Kodelja V, Muller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998; 160: 1411-18.
25. Politz O, Kodelja V, Guillot P, Orfanos CE, Goerdt S. Pseudoexons and regulatory elements in the genomic sequence of the beta-chemokine, alternative macrophage activation-associated CC-chemokine (AMAC)-1. Cytokine 2000; 12: 120-26.
26. Stahl PD. The mannose receptor and other macrophage lectins. Curr Opin Immunol 1992; 4: 49-52.
27. Geng YJ, Hansson GK. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992; 89: 1322-30.
28. Hogger P, Dreier J, Droste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998; 161: 1883-90.
29. Schaer DJ, Boretti FS, Schoedon G, Schaffner A. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol 2002; 119: 239-43.
30. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001; 53: 386-92.
31. Noel W, Hassanzadeh G, Raes G, Namangala B, Daems I, Brys L. Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect Immun 2002; 70: 6180-87.
32. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 2002; 3: 7.
33. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, Hassanzadeh GG. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 2002; 71: 597-602.
34. Nair MG, Cochrane DW, Allen JE. Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol Lett 2003; 85: 173-80.
35. Welch JS, Escoubet-Lozach L, Sykes DB, Glass CK. Th2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 2002; 277: 42821-9.
36. Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362: 155-64.
37. Adachi H, Tsujimoto M. FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities. J Biol Chem 2002; 277: 34 264-70.
38. Caputo R, Grimalt R. Solitary reticulohistiocytosis (reticulohistiocytoma) of the skin in children: report of two cases. Arch. Dermatol. 1992; 128: 698-99.
39. Caputo R, Ermacora E, Gelmetti C. Diffuse cutaneous reticulohistiocytosis in a child with tuberous sclerosis. Arch Dermatol 1988; 124: 567-70.
40. Fonseca E, Contreras F, Cuevas J. Papular xanthoma in children: report and immunohistochemical study. Pediatr Dermatol 1993; 10: 139-41.
41. Zelger BG, Zelger B, Steiner H, Mikuz G. Solitary giant xanthogranuloma and benign cephalic histiocytosis - variants of juvenile xanthogranuloma. Br J Dermatol 1995; 133: 598-604.
42. Gianotti R, Alessi E, Caputo R. Benign cephalic histiocytosis: a distinct entity or a part of a wide spectrum of histiocytic proliferative disorders of children? A histopathological study. Am J Dermatopathol 1993; 15: 315-19.
43. Senear FE, Caro MR. Naevoxanthoendothelioma or juvenile xanthoma. Arch Dermatol 1936; 34: 195-206.
44. Hernandez-Martin A, Baselga E, Drolet BA, Esterly NB. Juvenile xanthogranuloma. J Am Acad Dermatol 1997; 36: 355-67.
45. Freyer DR, Kennedy R, Bostrom BC, Kohut G, Dehner LP. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr 1996; 129: 227-37.
46. Dehen L, Zeller J, Cosnes A, Bernaudin F, Roujeau JC, Revuz J. [Xanthogranuloma, type I neurofibromatosis and myelomonocytic leukemia with spontaneous regression]. Ann Dermatol Venereol 1990; 117: 812-14.
47. Zvulunov A, Barak Y, Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol 1995; 131: 904-08.
48. Ashmore ED, Wilson MW, Morris WR, Hill DA, Rodriguez-Galindo C, Haik BG. Corneal juvenile xanthogranuloma in a 4-month-old child. Arch Ophthalmol 2003; 121: 117-18.
49. Fang TJ, Lin CZ, Li HY. Juvenile xanthogranuloma of the nasal cavity. Int J Pediatr Otorhinolaryngol 2003; 67: 297-99.
50. Chang MW. Update on juvenile xanthogranuloma: unusual cutaneous and systemic variants. Semin Cutan Med Surg 1999; 18: 195-205.
51. Gianotti F, Caputo R, Ermacora E. [Singular "infantile histiocytosis with cells with intracytoplasmic vermiform particles"]. Bull Soc Fr Dermatol Syphiligr 1971; 78: 232-33.
52. Goday JJ, Raton JA, Landa N, Eizaguirre X, Diaz-Perez JL. Benign cephalic histiocytosis-study of a case. Clin Exp Dermatol 1993; 18: 280-82.
53. Hogan PA, Morelli JG, Weston WL. An 18-month-old boy with a persistent papular eruption. Pediatr Dermatol 1993; 10: 195-97.
54. Barsky BL, Lao I, Barsky S, Rhee HL. Benign cephalic histiocytosis. Arch Dermatol 1984; 120: 650-55.
55. Jih DM, Salcedo SL, Jaworsky C. Benign cephalic histiocytosis: a case report and review. J Am Acad Dermatol 2002; 47: 908-13.
56. Weston WL, Travers SH, Mierau GW, Heasley D, Fitzpatrick J. Benign cephalic histiocytosis with diabetes insipidus. Pediatr Dermatol 2000; 17: 296-98.
57. Winkelmann RK, Muller SA. Generalized eruptive histiocytoma. A benign papular histiocytic rericulosis. Arch Dermatol 1963; 88: 586-96.
58. Winkelmann RK, Kossard S, Fraga S. Eruptive histiocytoma of childhood. Arch Dermatol 1980; 116: 565-70.
59. Caputo R, Ermacora E, Gelmetti C, Berti E, Gianni E, Nigro A. Generalized eruptive histiocytoma in children. J Am Acad Dermatol 1987; 17: 449-54.
60. Izaki S, Kitamura K, Arai E. Generalized eruptive histiocytoma: report of a pediatric case. J Dermatol 1993; 20: 105-08.
61. Wee SH, Kim HS, Chang SN, Kim DK, Park WH. Generalized eruptive histiocytoma: a pediatric case. Pediatr Dermatol 2000; 17: 453-55.
62. Misery L, Kanitakis J, Hermier C, Cambazard F. Generalized eruptive histiocytoma in an infant with healing in summer: long-term follow-up. Br J Dermatol 2001; 144: 435-37.
63. Matsushima Y, Ohnishi K, Ishikawa O. Generalized eruptive histiocytoma of childhood associated with rheumatic fever. Eur J Dermatol 1999; 9: 548-50.
64. Konohana A, Noda J, Koizumi M. Multiple xanthogranulomas in an adult. Clin Exp Dermatol 1993; 18: 462-63.
65. Rodriguez J, Ackerman AB. Xanthogranuloma in adults. Arch Dermatol 1976; 112: 43-44.
66. Sonoda T, Hashimoto H, Enjoji M. Juvenile xanthogranuloma. Clinicopathologic analysis and immunohistochemical study of 57 patients. Cancer 1985; 56: 2280-86.
67. Nakamura S, Izawa R, Nakayama K, Hoshi K, Onda S. Xanthogranuloma in the adult. J Dermatol 1983; 10: 151-56.
68. Sueki H, Saito T, Iijima M, Fujisawa R. Adult-onset xanthogranuloma appearing symmetrically on the ear lobes. J Am Acad Dermatol 1995; 32: 372-74.
69. Pehr K, Elie J, Watters AK. "Juvenile" xanthogranuloma in a 77-year-old man. Int J Dermatol 1994; 33: 438-41.
70. Castilla EA, Ormsby A. Adult xanthogranuloma of the vulva: case report and review. Pathology 2002; 34: 86-87.
71. Zelger B, Cerio R, Orchard G, Wilson-Jones E. Juvenile and adult xanthogranuloma. A histological and immunohistochemical comparison. Am J Surg Pathol 1994; 18: 126-35.
72. Winkelmann RK. Cutaneous syndromes of non-X histiocytosis. A review of the macrophage-histiocyte diseases of the skin. Arch Dermatol 1981; 117: 667-72.
73. Breier F, Zelger B, Reiter H, Gschnait F, Zelger BW. Papular xanthoma: a clinicopathological study of 10 cases. J Cutan Pathol 2002; 29: 200-06.
74. Kim SH, Koh KJ, Choi JH, Sung KJ, Moon KC, Koh JK. Congenital papular xanthoma. Br J Dermatol 2000; 142: 569-71.
75. Sanchez RL, Raimer SS, Peltier F, Swedo J. Papular xanthoma. A clinical, histologic, and ultrastructural study. Arch Dermatol 1985; 121: 626-31.
76. Goerdt S, Bonsmann G, Sunderkotter C, Grabbe S, Luger T, Kolde G. A unique non-Langerhans cell histiocytosis with some features of generalized eruptive histiocytoma. J Am Acad Dermatol 1994; 31: 322-26.
77. Stables GI, Mackie RM. Generalized eruptive histiocytoma. Br J Dermatol 1992; 126: 196-99.
78. Marzano AV, Facchetti M, Caputo R. Guess what! Generalized eruptive histiocytosis (histiocytoma). Eur J Dermatol 2002; 12: 205-06.
79. Klemke CD, Dippel E, Geilen CC, Koenigsmann MP, Thiel E, Orfanos CE. Atypical generalized eruptive histiocytosis associated with acute monocytic leukemia. J Am Acad Dermatol 2003; in press.
80. Statham BN, Fairris GM, Cotterill JA. Atypical eruptive histiocytosis - a marker of underlying malignancy? Br J Dermatol 1984; 110: 103-05.
81. Altman J, Winkelmann RK. Xanthoma disseminatum. Arch Dermatol 1962; 86: 582-89.
82. Varotti C, Bettoli V, Berti E, Cavicchini S, Caputo R. Xanthoma disseminatum: a case with extensive mucous membrane involvement. J Am Acad Dermatol 1991; 25: 433-36.
83. Davies CW, Marren P, Juniper MC, Gray W, Wojnorowska F, Benson MK. Xanthoma disseminatum with respiratory tract involvement and fatal outcome. Thorax 2000; 55: 170-72.
84. Baron J, Barrie JR, Raymond GS. Xanthoma disseminatum: a rare cause of upper airway narrowing. AJR Am J Roentgenol 2003; 180: 1180-81.
85. Szekeres E, Tiba A, Korom I. Xanthoma disseminatum: a rare condition with non-X, non-lipid cutaneous histiocytopathy. J Dermatol Surg Oncol 1988; 14: 1021-24.
86. Calverly DC, Wismer J, Rosenthal D, deSa D, Barr RD. Xanthoma disseminatum in an infant with skeletal and marrow involvement. J Pediatr Hematol Oncol 1995; 17: 61-65.
87. Caputo R, Veraldi S, Grimalt R, Gianotti R, Tosti A, Varotti C. The various clinical patterns of xanthoma disseminatum. Considerations on seven cases and review of the literature. Dermatology 1995; 190: 19-24.
88. Rupec RA, Schaller M. Xanthoma disseminatum. Int J Dermatol 2002; 41: 911-13.
89. Halprin KM, Lorincz AL. Disseminated xanthosiderohistiocytosis (xanthoma disseminatum). Report of a case and discussion of possible relationship to other disorders showing histiocytic proliferation. Arch Dermatol 1960; 82: 171-74.
90. Battaglini J, Olsen TG. Disseminated xanthosiderohistiocytosis, a variant of xanthoma disseminatum, in a patient with a plasma cell dyscrasia. J Am Acad Dermatol 1984; 11: 750-55.
91. Ferrando J, Campo-Voegeli A, Soler-Carrillo J, Munoz E, Sole M, Palou J. Systemic xanthohistiocytoma: a variant of xanthoma disseminatum? Br J Dermatol 1998; 138: 155-60.
92. Zelger B, Cerio R, Orchard G, Fritsch P, Wilson-Jones E. Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X. Arch Dermatol 1992; 128: 1207-12.
93. Goerdt S, Kretzschmar L, Bonsmann G, Luger T, Kolde G. Normolipemic papular xanthomatosis in erythrodermic atopic dermatitis. J. Am. Acad. Dermatol. 1995; 32: 326-33.
94. Carpo BG, Grevelink SV, Brady S, Gellis S, Grevelink JM. Treatment of cutaneous lesions of xanthoma disseminatum with a CO2 laser. Dermatol Surg 1999; 25: 751-54.
95. Cantarella G, Neglia CB, Marzano AV, Ottaviani A. Bilateral laryngeal pseudoparalysis in xanthoma disseminatum treated by endoscopic laser medial arytenoidectomy. Ann Otol Rhinol Laryngol 2001; 110: 263-67.
96. Goltz RW, Laymon CW. Multicentric reticulohistiocytosis of the skin and synovia. Arch Dermatol Syphilol 1954; 69: 717-30.
97. Stogmann W, Kerl H, Schmidberger H. [Lipoid dermatoarthritis (multicentric reticulohistiocytosis) (author's transl)]. Eur J Pediatr 1975; 121: 71-80.
98. Barrow MV, Holubar K. Multicentric reticulohistiocytosis. A review of 33 patients. Medicine (Baltimore) 1969; 48: 287-305.
99. Havill S, Duffill M, Rademaker M. Multicentric reticulohistiocytosis in a child. Australas J Dermatol 1999; 40: 44-46.
100. Outland JD, Keiran SJ, Schikler KN, Callen JP. Multicentric reticulohistiocytosis in a 14-year-old girl. Pediatr Dermatol 2002; 19: 527-31.
101. Campbell DA, Edwards NL. Multicentric reticulohistiocytosis: systemic macrophage disorder. Baillieres Clin Rheumatol 1991; 5: 301-19.
102. Katz RW, Anderson KF. Multicentric reticulohistiocytosis. Oral Surg Oral Med Oral Pathol 1988; 65: 721-25.
103. Finelli LG, Tenner LK, Ratz JL, Long BD. A case of multicentric reticulohistiocytosis with thyroid involvement. J Am Acad Dermatol 1986; 15: 1097-100.
104. Carey RN, Blotzer JW, Wolfe ID, Glusman SM, Arnett FC. Multicentric reticulohistiocytosis and Sjogren's syndrome. J Rheumatol 1985; 12: 1193-95.
105. Kuramoto Y, Iizawa O, Matsunaga J, Nakamura N, Tagami H. Development of Ki-1 lymphoma in a child suffering from multicentric reticulohistiocytosis. Acta Derm Venereol 1991; 71: 448-49.
106. Bauer A, Garbe C, Detmar M, Kreuser ED, Gollnick H. [Multicentric reticulohistiocytosis and myelodysplastic syndrome]. Hautarzt 1994; 45: 91-96.
107. Luz FB, Gaspar TAP, Kalil-Gaspar N, Ramos-e-Silva. Multicentric reticulohistiocytosis. J Eur Acad Dermatol Venereol 2001; 15: 524-31.
108. Blanco JJ, Hernandez FJ, Cerezo JG, Garcia IS, Rubio FC, Rodriguez JJ. Multicentric reticulohistiocytosis. The long course of a rare disease. Scand J Rheumatol 2002; 31: 107-09.
109. Heathcote JG, Guenther LC, Wallace AC. Multicentric reticulohistiocytosis: a report of a case and a review of the pathology. Pathology 1985; 17: 601-08.
110. Schmitt AM, Grolleau-Rochiccioli P, Laplanche G, Gorguet B, Manzur F, Bazex J. [Multicenter histiocytosis]. Ann Dermatol Venereol 1994; 121: 805-08.
111. Fedler R, Frantzmann Y, Schwarze EW, Frosch PJ. [Multicenter reticulohistiocytosis. Therapy with azathioprine and prednisolone]. Hautarzt 1995; 46: 118-20.
112. Chester W. Über Lipoidgranulomatose. Virchows Arch 1930; 279: 561-602.
113. Jaffe HL. Metabolic, degenerative and inflammatory diseases of bones and joints. München, Wien, Berlin: Urban & Schwarzenberg, 1972: 535-41.
114. Olmos JM, Canga A, Velero C, Gonzalez-Macias J, Imaging of Erdheim-Chester disease. J Bone Miner Res 2002; 17: 381-83.
115. Kujat C, Martin J, Puschel W. Erdheim-Chester disease. Radiologe 1991; 31: 297-306.
116. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75: 157-69.
117. Watermann DF, Kiesewetter F, Frosch PJ. Skin manifestations of Erdheim-Chester disease. Case report and review of the literature. Hautarzt 2001; 52: 510-17.
118. Gupta A, Kelly B, McGuigan JE. Erdheim-Chester disease with prominent pericardial involvement: clinical, radiologic, and histologic findings. Am J Med Sci 2002; 324: 96-100.
119. Yun EJ, Yeh BM, Yabes AP, Coakley FV, Kane CJ. Erdheim-Chester disease: case report and review of associated urological, radiological and histological features. J Urol 2003; 169: 1470-71.
120. Bohlega S, Alwatban J, Tulbah A, Bakheet SM, Powe J. Cerebral manifestation of Erdheim-Chester disease: clinical and radiologic findings. Neurology 1997; 49: 1702-05.
121. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma. Australas J Dermatol 1980; 21: 85-88.
122. Müller SA, Winkelmann RK. Atypical forms of necrobiosis lipoidica diabetorum: a report of 3 cases. Arch Pathol 1966; 81: 352-61.
123. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1980; 3: 257-70.
124. Finan MC, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases. Medicine (Baltimore) 1986; 65: 376-88.
125. Nestle FO, Hofbauer G, Burg G. Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. Dermatology 1999; 198: 434-35.
126. Venencie PY, Puissant A, Verola O, Kerneis Y, Marchat C, Le Bras P et al. Necrobiotic xanthogranuloma with myeloma. A case report. Cancer 1987; 59: 588-92.
127. Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 2000; 129: 651-57.
128. Finan MC, Winkelmann RK. Histopathology of necrobiotic xanthogranuloma with paraproteinemia. J Cutan Pathol 1987; 14: 92-99.
129. Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch Dermatol 1992; 128: 94-100.
130. Machado S, Alves R, Lima M, Leal I, Massa A. Cutaneous necrobiotic xanthogranuloma (NXG)-successfully treated with low dose chlorambucil. Eur J Dermatol 2001; 11: 458-62.
131. Macfarlane AW, Verbov JL, Necrobiotic xanthogranuloma with paraproteinaemia. Br J Dermatol 1985; 113: 339-43.
132. Criado PR, Vasconcellos C, Pegas JR, Lopes LF, Ramos CF, Tebcherani AJ. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone. J Dermatolog Treat 2002; 13: 87-89.
133. Chave TA, Chowdhury MM, Holt PJ. Recalcitrant necrobiotic xanthogranuloma responding to pulsed high-dose oral dexamethasone plus maintenance therapy with oral prednisolone. Br J Dermatol 2001; 144:158-61.
134. Finelli LG, Ratz JL. Plasmapheresis, a treatment modality for necrobiotic xanthogranuloma. J Am Acad Dermatol 1987; 17: 351-54.
135. Char DH, LeBoit PE, Ljung BM, Wara W. Radiation therapy for ocular necrobiotic xanthogranuloma. Arch Ophthalmol 1987; 105: 174-75.
136. Bork K, Hoede N. Hereditary progressive mucinous histiocytosis in women. Report of three members in a family. Arch Dermatol 1988; 124: 1225-29.
137. Antoni-Bach N, Pfister R, Grosshans E, Kleinclaus I, Boehm N, Grange F. Hereditary progressive mucinous histiocytosis. Ann Dermatol Venereol 2000; 127: 400-04.
138. Bork K. Hereditary progressive mucinous histiocytosis. Immunohistochemical and ultrastructural studies in an additional family. Arch Dermatol 1994; 130: 1300-04,
139. Schroder K, Hettmannsperger U, Schmuth M, Orfanos CE, Goerdt S. Hereditary progressive mucinous histiocytosis. J Am Acad Dermatol 1996; 35: 298-303.
140. Mizushima J, Nogita T, Higaki Y, Kawashima M. Hereditary progressive mucinous histiocytosis. Int J Dermatol 1997; 36: 958-60.
141. Wong D, Killingsworth M, Crosland G, Kossard S. Hereditary progressive mucinous histiocytosis. Br J Dermatol 1999; 141: 1101-05.
142. Sass U, Andre J, Song M. A sporadic case of progressive mucinous histiocytosis. Br J Dermatol 2000; 142: 133-37.
143. Taunton OD, Yeshurun D, Jarratt M. Progressive nodular histiocytoma. Arch Dermatol 1978; 114: 1505-08.
144. Burgdorf WH, Duray P, Rosai J. Immunohistochemical identification of lysozyme in cutaneous lesions of alleged histiocytic nature. Am J Clin Pathol 1981; 75: 162-67.
145. Torres L, Sanchez JL, Rivera A, Gonzalez A. Progressive nodular histiocytosis. J Am Acad Dermatol 1993; 29: 278-80.
146. Gonzalez RA, Bernal Ruiz AI, Aragoneses FH, Peral MI, Garcia MM. Progressive nodular histiocytosis accompanied by systemic disorders. Br J Dermatol 2000; 143: 628-31.
147. Beswick SJ, Kirk JM, Bradshaw K, Sanders DS, Moss C. Progressive nodular histiocytosis in a child with a hypothalamic tumor. Br J Dermatol 2002; 146: 138-40.